Over the past decade, several tumor-based predictors of cetuximab efficacy have been identified, yet most function as ...
Insulet could be joining the competition to develop 'artificial pancreas' devices following the release of positive feasibility data for its solution. The Massachusetts-based company's 'hybrid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback